Homologs of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
US5032573A · kind A · utility
13Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 1989 |
| Grant date | Jul 16, 1991 |
| Priority date | — |
| Expiry date | Oct 2, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Microbially produced aprotinin and aprotinin homologs used for treating patients suffering from an excess release of pancreatic elastase, serum elastase or leukocyte elastase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.